Prologue Medicines is a biotechnology company focused on discovering and developing novel therapeutics by leveraging advanced computational biology and machine learning. They generate revenue through partnerships, licensing agreements, and the commercialization of their proprietary drug candidates. Founded in 2020, the company has quickly established itself as a leader in the integration of AI with drug discovery, aiming to address unmet medical needs and improve patient outcomes.